Schizophrenia genomics and proteomics: Are we any closer to biomarker discovery?

Behavioral and Brain Functions

Volumn 5, Issue , 2009, Pages

  Lakhan, Shaheen E ^a   Kramer, Alon ^a  

^a Global Neuroscience Initiative Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DISRUPTED IN SCHIZOPHRENIA 1PROTEIN; DYSBINDIN; GLUCOSE; ISOPROSTANE DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

BRAIN TISSUE; CEREBROSPINAL FLUID; DISEASE MARKER; ENDOPHENOTYPE; ETHNIC DIFFERENCE; FAMILY STUDY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GLUCOSE BLOOD LEVEL; HUMAN; MULTIGENE FAMILY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; URINALYSIS;

EID: 58749105661     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-5-2     Document Type: Review

References (63)

1. McGrath J Saha S Welham J El Saadi O MacCauley C Chant D A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology BMC Med 2004, 2:13. 421751 15115547
2. Lakhan SE Schizophrenia proteomics: Biomarkers on the path to laboratory medicine? Diagn Pathol 2006, 1:11. 1538632 16846510
3. Heinrichs RW Historical origins of schizophrenia: Two early madmen and their illness J Hist Behav Sci 2003, 39:349-63. 14601041
4. Sunderland T Gur RE Arnold SE The use of biomarkers in the elderly: current and future challenges Biol Psychiatry 2005, 58:272-6. 16018985
5. Bibl M Wiltfang J Diagnostic and prognostic needs in neurodegenerative disorders: Focus on proteomics Expert Rev Proteomics 2008, 5:153-6. 18466046
6. Riley B Kendler KS Molecular genetic studies of schizophrenia Eur J Hum Genet 2006, 14:669-80. 16721403
7. Allen NC Bagade S McQueen MB Ioannidis JP Kavvoura FK Khoury MJ Tanzi RE Bertram L Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database Nat Genet 2008, 40:827-34. 18583979
8. Bertram L Genetic research in schizophrenia: New tools and future perspectives Schizophr Bull 2008, 34:806-12. 18644854
9. Sun J Kuo PH Riley BP Kendler KS Zhao Z Candidate genes for schizophrenia: A survey of association studies and gene ranking Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1173-81. 18361404
10. Camargo LM Collura V Rain JC Mizuguchi K Hermjakob H Kerrien S Bonnert TP Whiting PJ Brandon NJ Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia Mol Psychiatry 2007, 12:74-86. 17043677
11. Camargo LM Wang Q Brandon NJ What can we learn from the disrupted in schizophrenia 1 interactome: Lessons for target identification and disease biology? Novartis Found Symp 2008, 289:208-16. 18497105
12. Roberts RC Schizophrenia in translation: Disrupted in schizophrenia (DISC1): Integrating clinical and basic findings Schizophr Bull 2007, 33:11-5. 17138582
13. Fanous AH Kendler KS Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature Curr Psychiatry Rep 2008, 10:164-70. 18474210
14. Edwards TL Wang X Chen Q Wormly B Riley B O'Neill FA Walsh D Ritchie MD Kendler KS Chen X Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia Schizophr Res 2008, 106:208-17. 18804346
15. Owen MJ Craddock N Jablensky A The genetic deconstruction of psychosis Schizophr Bull 2007, 33:905-11. 17551090
16. Gottesman II Gould TD The endophenotype concept in psychiatry: Etymology and strategic intentions Am J Psychiatry 2003, 160:636-45. 12668349
17. Braff D Schork NJ Gottesman II Endophenotyping schizophrenia Am J Psychiatry 2007, 164:705-7. 17475726
18. Chen Y Bidwell LC Norton D Trait vs. State Markers for Schizophrenia: Identification and characterization through visual processes Curr Psychiatry Rev 2006, 2:431-438. 1866220 17487285
19. Bender S Weisbrod M Resch F Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia? J Neural Transm 2007, 114:1199-215. 17514428
20. Kumar D Nizamie SH Jahan M Activity-based prospective memory in schizophrenia Clin Neuropsychol 2008, 22:497-506. 17853129
21. Wang Y Chan RC Hong X Ma Z Yang T Guo L Yu X Li Z Yuan Y Gong QY Shum D Prospective memory in schizophrenia: Further clarification of nature of impairment Schizophr Res 2008. 105:114-24. 18707848
22. Skelley SL Goldberg TE Egan MF Weinberger DR Gold JM Verbal and visual memory: Characterizing the clinical and intermediate phenotype in schizophrenia Schizophr Res 2008, 105:78-85. 18617370
23. Veenstra TD Marcus K Multidimensional advancement of neuroproteomics Expert Rev Proteomics 2008, 5:149-51. 18466109
24. Bibl M Esselmann H Mollenhauer B Weniger G Welge V Liess M Lewczuk P Otto M Schulz JB Trenkwalder C Kornhuber J Wiltfang J Blood-based neurochemical diagnosis of vascular dementia: A pilot study J Neurochem 2007, 103:467-74. 17662050
25. Ray S Britschgi M Herbert C Takeda-Uchimura Y Boxer A Blennow K Friedman LF Galasko DR Jutel M Karydas A Kaye JA Leszek J Miller BL Minthon L Quinn JF Rabinovici GD Robinson WH Sabbagh MN So YT Sparks DL Tabaton M Tinklenberg J Yesavage JA Tibshirani R Wyss-Coray T Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nat Med 2007, 13:1359-62. 17934472
26. Coelho FM Reis HJ Nicolato R Romano-Silva MA Teixeira MM Bauer ME Teixeira AL Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia Neuroimmunomodulation 2008, 15:140-4. 18679053
27. Dietrich-Muszalska A Olas B The changes of aggregability of blood platelets in schizophrenia World J Biol Psychiatry 1-6 2007, Sep 14 17886164
28. Dietrich-Muszalska A Olas B Rabe-Jablonska J Oxidative stress in blood platelets from schizophrenic patients Platelets 2005, 16:386-91. 16236599
29. Porton B Delisi LE Bertisch HC Ji F Gordon D Li P Benedict MM Greenberg WM Kao HT Telomerase levels in schizophrenia: A preliminary study Schizophr Res 2008, 106:242-7. 18829263
30. Decramer S Gonzalez de Peredo A Breuil B Mischak H Monsarrat B Bascands JL Schanstra JP Urine in clinical proteomics Mol Cell Proteomics 2008, 7:1850-62. 18667409
31. Thongboonkerd V Practical points in urinary proteomics J Proteome Res 2007, 6:3881-90. 17824635
32. Dietrich-Muszalska A Olas B Isoprostenes as indicators of oxidative stress in schizophrenia World J Biol Psychiatry 1-7. 17853282
33. Tuppo EE Forman LJ Spur BW Chan-Ting RE Chopra A Cavalieri TA Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease Brain Res Bull 2001, 54:565-8. 11397549
34. Miyaoka T Yasukawa R Yasuda H Shimizu M Mizuno S Sukegawa T Inagaki T Horiguchi J Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders Eur Neuropsychopharmacol 2005, 15:249-52. 15820412
35. Huang JT Leweke FM Tsang TM Koethe D Kranaster L Gerth CW Gross S Schreiber D Ruhrmann S Schultze-Lutter F Klosterkötter J Holmes E Bahn S CSF metabolic and proteomic profiles in patients prodromal for psychosis PLoS ONE 2007, 2:e756. 1942084 17712404
36. Huang JT McKenna T Hughes C Leweke FM Schwarz E Bahn S CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects J Sep Sci 2007, 30:214-25. 17390615
37. Peskind ER Riekse R Quinn JF Kaye J Clark CM Farlow MR Decarli C Chabal C Vavrek D Raskind MA Galasko D Safety and acceptability of the research lumbar puncture Alzheimer Dis Assoc Disord 2005, 19:220-5. 16327349
38. Hindley NJ Jobst KA King E Barnetson L Smith A Haigh AM High acceptability and low morbidity of diagnostic lumbar puncture in elderly subjects of mixed cognitive status Acta Neurol Scand 1995, 91:405-11. 7639073
39. Hampel H Bürger K Teipel SJ Bokde AL Zetterberg H Blennow K Core candidate neurochemical and imaging biomarkers of Alzheimer's disease Alzheimers Dement 2008, 4:38-48. 18631949
40. Süssmuth SD Brettschneider J Ludolph AC Tumani H Biochemical markers in CSF of ALS patients Curr Med Chem 2008, 15:1788-801. 18691039
41. Bibl M Mollenhauer B Lewczuk P Esselmann H Wolf S Trenkwalder C Otto M Stiens G Rüther E Kornhuber J Wiltfang J Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias Mol Psychiatry 2007, 12:671-80. 17339876
42. Zhang J Sokal I Peskind ER Quinn JF Jankovic J Kenney C Chung KA Millard SP Nutt JG Montine TJ CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases Am J Clin Pathol 2008, 129:526-9. 18343778
43. Miller CL Llenos IC Cwik M Walkup J Weis S Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder Neurochem Int 2008 52 1297 303 18328600
44. Miller CL Dulay JR The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia Brain Res Bull 2008, 77:33-41. 18639743
45. Ranganathan S Nicholl GC Henry S Lutka F Sathanoori R Lacomis D Bowser R Comparative proteomic profiling of cerebrospinal fluid between living and post mortem ALS and control subjects Amyotroph Lateral Scler 2007, 8(6):373-379. 17852009
46. Bell JE Alafuzoff I Al-Sarraj S Arzberger T Bogdanovic N Budka H Dexter DT Falkai P Ferrer I Gelpi E Gentleman SM Giaccone G Huitinga I Ironside JW Klioueva N Kovacs GG Meyronet D Palkovits M Parchi P Patsouris E Reynolds R Riederer P Roggendorf W Seilhean D Schmitt A Schmitz P Streichenberger N Schwalber A Kretzschmar H Management of a twenty-first century brain bank: Experience in the BrainNet Europe consortium Acta Neuropathol 2008, 115:497-507. 18365220
47. Ravid R Standard Operating Procedures, ethical and legal regulations in BTB (Brain/Tissue/Bio) banking: What is still missing? Cell Tissue Bank 2008, 9:121-37. 17985213
48. Troyer D Biorepository standards and protocols for collecting, processing, and storing human tissues Methods Mol Biol 2008, 441:193-220. 18370320
49. Graeber MB Twenty-first century brain banking: At the crossroads Acta Neuropathol 2008 ,115:493-6. 18347804
50. Frankfort SV Tulner LR van Campen JP Verbeek MM Jansen RW Beijnen JH Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: A review of recent literature Curr Clin Pharmacol 2008, 3:123-31. 18700307
51. Schmitt A Parlapani E Bauer M Heinsen H Falkai P Is brain banking of psychiatric cases valuable for neurobiological research? Clinics 2008, 63:255-66. 18438581
52. Brandon NJ Dissecting DISC1 function through protein-protein interactions Biochem Soc Trans 2007, 35:1283-6. 17956330
53. Burdick KE Kamiya A Hodgkinson CA Lencz T DeRosse P Ishizuka K Elashvili S Arai H Goldman D Sawa A Malhotra AK Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: Evidence of epistasis and competitive binding Hum Mol Genet 2008, 17:2462-73. 2486442 18469341
54. Millar JK Mackie S Clapcote SJ Murdoch H Pickard BS Christie S Muir WJ Blackwood DH Roder JC Houslay MD Porteous DJ Disrupted in schizophrenia 1 and phosphodiesterase 4B: Towards an understanding of psychiatric illness J Physiol 2007, 584:401-5. 2277141 17823207
55. Guo AY Sun J Riley BP Thiselton DL Kendler KS Zhao Z The dystrobrevin-binding protein 1 gene: Features and networks Mol Psychiatry 2009, 14(1):18-29. 18663367
56. Yang CY Chang CH Yu YL Lin TC Lee SA Yen CC Yang JM Lai JM Hong YR Tseng TL Chao KM Huang CY PhosphoPOINT: A comprehensive human kinase interactome and phospho-protein database Bioinformatics 2008, 24:i14-20. 18689816
57. Holmes E Tsang TM Huang JT Leweke FM Koethe D Gerth CW Nolden BM Gross S Schreiber D Nicholson JK Bahn S Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia PLoS Med 2006, 3:e327. 1551919 16933966
58. Baldaçara L Borgio JG de Lacerda AL Jackowski AP Cerebellum and psychiatric disorders Rev Bras Psiquiatr 2008, 30:281-9. 18833430
59. Lutkenhoff ES van Erp TG Thomas MA Therman S Manninen M Huttunen MO Kaprio J Lönnqvist J O'Neill J Cannon TD Proton MRS in twin pairs discordant for schizophrenia Mol Psychiatry 18645571
60. Kubicki M Styner M Bouix S Gerig G Markant D Smith K Kikinis R McCarley RW Shenton ME Reduced interhemispheric connectivity in schizophrenia-tractography based segmentation of the corpus callosum Schizophr Res 2008, 106:125-131. 18829262
61. Windemuth A Calhoun VD Pearlson GD Kocherla M Jagannathan K Ruaño G Physiogenomic analysis of localized FMRI brain activity in schizophrenia Ann Biomed Eng 2008, 36:877-88. 18330705
62. Giedd JN Lenroot RK Shaw P Lalonde F Celano M White S Tossell J Addington A Gogtay N Trajectories of anatomic brain development as a phenotype Novartis Found Symp 2008, 289:101-12. 18497098
63. Takahashi T Suzuki M Tsunoda M Kawamura Y Takahashi N Maeno N Kawasaki Y Zhou SY Hagino H Niu L Tsuneki H Kobayashi S Sasaoka T Seto H Kurachi M Ozaki N The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1236-42. 18472202